Introduction
Immunoglobulin (Ig) G4-associated cholangitis (IAC) is an inflammatory disease of the biliary tree which is characterized by elevated serum IgG4 levels and infiltration of IgG4+ plasma cells in the bile duct walls [1] . IAC typically shows excellent response to immunosuppressive treatment. However, relapse rates after tapering of immunosuppression are considerable, ranging from 30 to Hubers We recently reported that the majority of two independent cohorts of patients with IgG4-RD consisted of 'blue-collar workers' with long-term (>1 year) or lifelong exposure to industrial solvents and gases [7] . Cross-validation of these findings in additional independent cohorts is needed.
Biochemical Tests
Serum liver tests show a cholestatic pattern with often marked elevation of alkaline phosphatase (ALP) and γ-GT and only mildly increased ALT and AST. Serum bilirubin may be increased. Serum IgG4 levels are elevated (>140 mg/dl) in up to 75-80% of affected patients [1, 8, 9] ; however, this marker shows merely limited sensitivity and specificity when only modestly elevated (<4× upper limit of normal (ULN)) [8] as 10-15% of patients with pancreatobiliary cancers and PSC may also exhibit increased IgG4 levels [8, 9] . The tumor marker CA 19-9 is not able to distinguish pancreatobiliary malignancies from IAC since levels of >1,000 IU/ml (ULN = 37 IU/ ml) may be observed in IAC. Thus far, no disease-specific serum markers have been identified but are awaited in the near future [10] .
Radiographic Features
Cholangiography (endoscopic retrograde cholangiography or magnetic resonance pancreatocholangiography) and computed tomography with intravenous contrast may show strictures in the biliary tree with thickening and enhancement of the bile duct wall, dilatation of the upstream bile ducts, and sometimes a soft-tissue mass suspect for malignancy [11] . Depending on the localization of the stenosis and soft-tissue mass, IAC is easily misinterpreted as intra-or extrahepatic cholangiocarcinoma or pancreatic carcinoma ( fig. 1) . Also, locoregional lymphadenopathy may be present. Even vascular invasion, which is associated with malignancy [12] , may be seen in IAC. Sometimes multifocal strictures of intra-and extrahepatic bile ducts with a beaded or pruned-tree appearance are seen, mimicking PSC. However, PSC normally presents earlier in life than IAC (range 20-40 years of age). No radiographic features can clearly distinguish between these different entities [13] . However, extrabiliary involvement, especially of the pancreas, is highly suggestive of IAC. Characteristic features are a diffusely enlarged sausage-shaped pancreas, minimal peripancreatic fat stranding, a hypoattenuating rim ('halo'), and irregular narrowing of the pancreatic duct with an attenuated wall ( fig. 2) [14] . However, AIP may also present as a (multi-)focal mass in the head and/or tail of the pancreas with focal pancreatic duct stricture(s).
Histopathological Findings
Bile duct biopsies typically reveal a combination of a lymphoplasmacytic infiltrate consisting of high numbers of IgG4+ plasma/B cells (>10/per high power field (hpf)), storiform fibrosis, and obliterative phlebitis [5] . The diagnostic accuracy of the number of IgG4+ cells greatly depends on the chosen cut-off value and varies among tissues. In a case-control study on endoscopic biopsies of the ampulla of Vater and bile duct wall, a threshold of 10 IgG4+ cells/hpf yielded limited sensitivity but reasonable specificity (bile duct biopsies: 52% sensitivity and 89% specificity; ampulla of Vater biopsy: 52% sensitivity and 96% specificity) [15] . A cut-off of 20 IgG4+ cells/hpf increased specificity -at the cost of even lower sensitivities.
Also, the diagnostic value of brush cytology during cholangiography or stent (re-)placement, used for the diagnosis of pancreatobiliary malignancies, is poor with sensitivity rates of 50% [16] . Besides, prolonged stenting of the biliary tract may induce inflammation and cholangiocyte proliferation, making it hard to distinguish between benign and malignant cells and leading to false-positive results. 
Diagnostic Criteria
Several diagnostic consensus criteria have been developed in the past decade, including the HISORt (Histology, Imaging, Serology, Other organ involvement, and Response to therapy) criteria [1, 17] and international diagnostic consensus criteria (ICDC) [18] , as no single biomarker has proven to be accurate in diagnosing IAC. These combine histopathological, radiographic, and laboratory characteristics with responsiveness to immunosuppressive treatment and multi-organ involvement. A diagnostic flow diagram summarizing the widely used HISORt criteria is shown in figure 3 . The Boston criteria describe characteristic histopathological features [5] .
New Diagnostic Markers
Recently, clonally expanded IgG4+ B cells were found in the blood and affected tissues of patients with IAC by novel next-generation sequencing techniques; however, these were not present in healthy and disease control patients. Besides, these dominant B clones disappeared upon successful steroid treatment [10] . In confirmation of these findings, high numbers of circulating plasmablasts detected by flow cytometry were described to be specific for several organ manifestations of IgG4-related disease [19] . Prospective trials must be conducted to evaluate whether these new biomarkers are suitable for clinical use.
